When it comes to treating malaria, patient adherence is crucial for ensuring the success of the treatment. Unfortunately, in Africa, one of our products – Artemether and Lumefantrine suspension – was struggling with low patient adherence due to the unpleasant flavor of the suspension.
However, we weren’t about to let that stand in the way of helping our patients.
So, we took this challenge to our R&D team, determined to find a solution. We were delighted when they delivered this amazing result – by improving the flavor of the suspension to a delicious banana taste and patient adherence soared.
But we didn’t stop there – we also added a palatable apple flavor to the lineup, making our antimalarial suspension not only effective, but also enjoyable for patients.
It’s moments like these that remind us of the power of collaboration and innovation.